Annual ROE
-237.22%
+67.15%+22.06%
31 December 2023
Summary:
Salarius Pharmaceuticals annual return on equity is currently -237.22%, with the most recent change of +67.15% (+22.06%) on 31 December 2023. During the last 3 years, it has fallen by -192.31% (-428.21%). SLRX annual ROE is now -650.46% below its all-time high of -31.61%, reached on 31 December 2015.SLRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-140.30%
+8.34%+5.61%
30 September 2024
Summary:
Salarius Pharmaceuticals quarterly return on equity is currently -140.30%, with the most recent change of +8.34% (+5.61%) on 30 September 2024. Over the past year, it has increased by +96.64% (+40.79%). SLRX quarterly ROE is now -1107.40% below its all-time high of -11.62%, reached on 30 September 2014.SLRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.1% | +40.8% |
| 3 y3 years | -428.2% | -384.3% |
| 5 y5 years | -107.7% | -56.9% |
SLRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -619.5% | +22.1% | -384.3% | +52.1% |
| 5 y | 5 years | -619.5% | +22.1% | -414.7% | +52.1% |
| alltime | all time | -650.5% | +22.1% | -1107.4% | +52.1% |
Salarius Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -140.30%(-5.6%) |
| June 2024 | - | -148.64%(-2.3%) |
| Mar 2024 | - | -152.21%(-23.1%) |
| Dec 2023 | -237.22%(-22.1%) | -197.96%(-16.5%) |
| Sept 2023 | - | -236.94%(-19.1%) |
| June 2023 | - | -292.88%(+50.6%) |
| Mar 2023 | - | -194.45%(+40.4%) |
| Dec 2022 | -304.37%(+823.2%) | -138.48%(+41.2%) |
| Sept 2022 | - | -98.10%(+91.4%) |
| June 2022 | - | -51.26%(+20.9%) |
| Mar 2022 | - | -42.39%(+31.6%) |
| Dec 2021 | -32.97%(-26.6%) | -32.22%(+11.2%) |
| Sept 2021 | - | -28.97%(+6.3%) |
| June 2021 | - | -27.26%(-3.2%) |
| Mar 2021 | - | -28.17%(-32.4%) |
| Dec 2020 | -44.91%(-35.7%) | -41.68%(-15.4%) |
| Sept 2020 | - | -49.27%(-27.9%) |
| June 2020 | - | -68.37%(-5.7%) |
| Mar 2020 | - | -72.52%(-18.5%) |
| Dec 2019 | -69.84% | -88.94%(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -89.43%(+8.3%) |
| June 2019 | - | -82.57%(-34.8%) |
| Mar 2019 | - | -126.62%(-2.1%) |
| Dec 2018 | -114.21%(+46.6%) | -129.35%(+3.4%) |
| Sept 2018 | - | -125.15%(+4.9%) |
| June 2018 | - | -119.36%(+27.7%) |
| Mar 2018 | - | -93.49%(+20.2%) |
| Dec 2017 | -77.88%(+49.4%) | -77.79%(+17.1%) |
| Sept 2017 | - | -66.42%(+10.8%) |
| June 2017 | - | -59.97%(+5.7%) |
| Mar 2017 | - | -56.71%(+2.1%) |
| Dec 2016 | -52.13%(+64.9%) | -55.56%(+11.6%) |
| Sept 2016 | - | -49.79%(+17.5%) |
| June 2016 | - | -42.39%(+22.8%) |
| Mar 2016 | - | -34.53%(+19.9%) |
| Dec 2015 | -31.61% | -28.79%(+41.3%) |
| Sept 2015 | - | -20.38%(+12.9%) |
| June 2015 | - | -18.05%(+29.3%) |
| Mar 2015 | - | -13.96%(+20.1%) |
| Sept 2014 | - | -11.62% |
FAQ
- What is Salarius Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual ROE year-on-year change?
- What is Salarius Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly ROE year-on-year change?
What is Salarius Pharmaceuticals annual return on equity?
The current annual ROE of SLRX is -237.22%
What is the all time high annual ROE for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual return on equity is -31.61%
What is Salarius Pharmaceuticals annual ROE year-on-year change?
Over the past year, SLRX annual return on equity has changed by +67.15% (+22.06%)
What is Salarius Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SLRX is -140.30%
What is the all time high quarterly ROE for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly return on equity is -11.62%
What is Salarius Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SLRX quarterly return on equity has changed by +96.64% (+40.79%)